EUVIMEDEUVIMED entdecken
Vergleichsstudie

Multiparametric gadoxetic acid-enhanced MR versus dual-layer spectral detector CT for differentiating hepatocellular carcinoma from hypervascular pseudolesions

Akahiko Sato, Masahiro Okada iD, Kenichiro Tago, Yujiro Nakazawa, Mariko Mizuno, Takahiro Miyauchi, Yuko Kobashi

Acta Radiologica · 2025

DOI: 10.1177/02841851251323965 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Acta Radiologica, 2025. Verfasst von Akahiko Sato und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Nihon University School of Medicine, Itabashi-ku, Tokyo, Japan. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Gadolinium DTPA, Contrast Media. Die Arbeit nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

It can be difficult to differentiate hypervascular hepatocellular carcinoma (HCC) from hypervascular pseudolesion (HPL) such as arteriovenous shunts.

Purpose

To determine retrospectively whether double-layer detector computed tomography (DLCT) can differentiate HCC from HPL compared to gadoxetate-enhanced magnetic resonance imaging (EOB-MRI). Material and Methods We retrospectively analyzed 46 patients who underwent EOB-MRI and DLCT for suspected HCCs. Arterial/portal phase and hepatobiliary phase (HBP) on EOB-MRI, T2-weighted (T2W) imaging, diffusion-weighted imaging (DWI), apparent diffusion coefficient (ADC), CT value, iodine-density (ID), atomic-number (Zeff), and electron-density (ED) of the lesion and liver were evaluated. The reduction rates of ID (R-ID) between each phase of the arterial/portal phase on EOB-MRI were calculated. ROC analysis was performed to determine the accuracy for differentiating HCC from HPL.

Results

There were 55 HCCs and 14 HPLs. On DWI, 42, 11, and two HCCs showed high, slightly high, and iso intensity, respectively. However, all 14 HPLs showed iso intensity on DWI. Area under ROC curve (AUC) of DWI (0.982, 95% confidence interval [CI]=0.957–1) was significantly higher than that of HBP (AUC=0.714; 95% CI=0.580–0.849; P < 0.001), R-ID (AUC=0.742, 95% CI=0.580–0.903; P = 0.004), and ED of portal phase (AUC=0.786, 95% CI=0.640–0.891; P = 0.001) in differentiating HCC and HPL. ADC (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsGadolinium DTPAContrast MediaMagnetic Resonance ImagingTomography, X-Ray ComputedImage EnhancementHumansMaleFemaleDiagnosis, DifferentialMiddle AgedRetrospective StudiesAgedAdultLiverAged, 80 and overSensitivity and Specificity

Stichwörter der Autor:innen

Hepatocellular carcinomadiffusion-weighted imagingdual-energy computed tomographygadoxetic acid-enhanced magnetic resonancepseudolesion

Substanzen

gadolinium ethoxybenzyl DTPAGadolinium DTPAContrast Media

Autor:innen und Institutionen

  • Department of Radiology, Nihon University School of Medicine, Itabashi-ku, Tokyo, Japan.

ORCID-Profile: Masahiro Okada

Zitieren

APA

Sato, A., Okada, M., Tago, K., Nakazawa, Y., Mizuno, M., Miyauchi, T., & Kobashi, Y. (2025). Multiparametric gadoxetic acid-enhanced MR versus dual-layer spectral detector CT for differentiating hepatocellular carcinoma from hypervascular pseudolesions. Acta Radiologica. https://doi.org/10.1177/02841851251323965

Vancouver

Sato A, Okada M, Tago K, Nakazawa Y, Mizuno M, Miyauchi T, et al. Multiparametric gadoxetic acid-enhanced MR versus dual-layer spectral detector CT for differentiating hepatocellular carcinoma from hypervascular pseudolesions. Acta Radiologica. 2025. doi:10.1177/02841851251323965

BibTeX
@article{Sato2025,
  author = {Sato, Akahiko and Okada, Masahiro and Tago, Kenichiro and Nakazawa, Yujiro and Mizuno, Mariko and Miyauchi, Takahiro and Kobashi, Yuko},
  title = {Multiparametric gadoxetic acid-enhanced MR versus dual-layer spectral detector CT for differentiating hepatocellular carcinoma from hypervascular pseudolesions},
  journal = {Acta Radiologica},
  year = {2025},
  doi = {10.1177/02841851251323965}
}
Kostenlos starten →